165 related articles for article (PubMed ID: 19020377)
1. Hypopituitary control and complications study (HypoCCS): a decade of an outcomes assessment observational study.
Lamberts SW
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):2-5. PubMed ID: 19020377
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of current growth hormone treatments and future therapies.
Ross R
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):48-51. PubMed ID: 19020386
[TBL] [Abstract][Full Text] [Related]
4. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database.
Spielhagen C; Schwahn C; Möller K; Friedrich N; Kohlmann T; Moock J; Kołtowska-Häggström M; Nauck M; Buchfelder M; Wallaschofski H
Growth Horm IGF Res; 2011 Feb; 21(1):1-10. PubMed ID: 21093334
[TBL] [Abstract][Full Text] [Related]
5. Measurements of quality of life in patients with growth hormone deficiency.
Webb SM
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
[TBL] [Abstract][Full Text] [Related]
6. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
7. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients.
Götherström G; Bengtsson BA; Sunnerhagen KS; Johannsson G; Svensson J
Clin Endocrinol (Oxf); 2005 Jan; 62(1):105-13. PubMed ID: 15638878
[TBL] [Abstract][Full Text] [Related]
8. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy.
Fernholm R; Thoren M; Hoybye C; Anderstam B; Pernow Y; Saaf M; Hall K
Growth Horm IGF Res; 2009 Jun; 19(3):206-11. PubMed ID: 18990596
[TBL] [Abstract][Full Text] [Related]
9. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency.
Scaroni C; Ceccato F; Rizzati S; Mantero F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):61-5. PubMed ID: 19020389
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report.
Bohdanowicz-Pawlak A; Szymczak J; Bladowska J; Bednarek-Tupikowska G; Bidzińska B; Milewicz A
Med Sci Monit; 2006 Feb; 12(2):CR75-80. PubMed ID: 16449951
[TBL] [Abstract][Full Text] [Related]
12. Childhood-onset growth hormone (GH) deficiency in adult life.
Lissett CA; Shalet SM
Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):209-24. PubMed ID: 12064889
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of adult growth hormone deficiency (aGHD) resulting from brain injury--role of aGHD].
Arita K; Hirano H; Tominaga A; Kurisu K
Brain Nerve; 2008 Dec; 60(12):1445-54. PubMed ID: 19110756
[TBL] [Abstract][Full Text] [Related]
14. Update on epidemiology, etiology, and diagnosis of adult growth hormone deficiency.
Prodam F; Pagano L; Corneli G; Golisano G; Belcastro S; Busti A; Gasco V; Beccuti G; Grottoli S; Di Somma C; Colao A; Ghigo E; Aimaretti G
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):6-11. PubMed ID: 19020378
[TBL] [Abstract][Full Text] [Related]
15. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
Agha A; Walker D; Perry L; Drake WM; Chew SL; Jenkins PJ; Grossman AB; Monson JP
Clin Endocrinol (Oxf); 2007 Jan; 66(1):72-7. PubMed ID: 17201804
[TBL] [Abstract][Full Text] [Related]
16. Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS).
Rochira V; Mossetto G; Jia N; Cannavo S; Beck-Peccoz P; Aimaretti G; Ambrosio MR; Di Somma C; Losa M; Ferone D; Lubrano C; Scaroni C; Giampietro A; Corsello SM; Poggi M
J Endocrinol Invest; 2018 Nov; 41(11):1259-1266. PubMed ID: 29536433
[TBL] [Abstract][Full Text] [Related]
17. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
[TBL] [Abstract][Full Text] [Related]
18. Defining growth hormone status in adults with hypopituitarism.
Kaushal K; Shalet SM
Horm Res; 2007; 68(4):185-94. PubMed ID: 17389809
[TBL] [Abstract][Full Text] [Related]
19. Appropriate use of stimulation tests and insulin-like growth factor-I in obesity.
Di Somma C; Savastano S; Rota F; Savanelli MC; Pagano L; Pizza G; Lombardi G; Aimaretti G; Colao A
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):21-6. PubMed ID: 19020381
[TBL] [Abstract][Full Text] [Related]
20. Management of growth hormone deficiency in adults.
Nilsson AG; Svensson J; Johannsson G
Growth Horm IGF Res; 2007 Dec; 17(6):441-62. PubMed ID: 17629530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
